Although all three CAM receptors have been defined as suitable target ligands for colonic disease treatment, VCAM-1 has recently garnered particular interest after being revealed as a critical facilitator of colon tumour survival and metastasis in addition to its established role in intestinal inflammation [51]. The gene discussed is VCAM1; the disease is colonic disorder.